Rangnath Mishra, PhD

Rangnath Mishra
Rangnath Mishra, PhD, is a researcher at National Jewish Health. Dr. Mishra is in the Division of Oncology and Department of Medicine.
Department of Medicine
Division of Oncology, Cancer Center
Research AreasResearch Areas
  • Biomedical Informatics
  • Cancer
  • Cellular and Molecular Biology

Special Interests

Research Interests

Main focus of our laboratory is on cell signaling pathways involved in lung injury and lung cancer. HER2, a receptor of EGFR family of receptors, is activated by Neuregulin-1 in injuries leading to activation of a cascade of signaling pathways. Our research findings demonstrate that Neuregulin-1 is involved in progression of lung injury and fibrosis. We are investigating role of ADAM-17 in progression of NRG-1-pathway mediated lung injury.


Banaras Hindu University (Varanasi, India), PhD


Mishra, R, Cool, BL, Laderoute, KR, Foretz, M, Viollet, B, Simonson, MS. J. Biol. Chem. 283, 10461-10469 (2008).

Mishra, R, Zhu, L, Eckert, RL, Simonson, MS. Am. J. Physiol. Cell Physiol. 292: C1361-9 (2007).

Mishra, R, Emancipator, SN, Miller, C, Kern, T, and Simonson, MS. Am. J. Physiol. Renal Physiol. 286: F913-F921 (2004).

Mishra, R, Leahy, P, and Simonson MS. Am. J. Physiol. Cell Physiol. 285:C1109-15 (2003).

Mishra, R, Leahy, P, and Simonson, MS. Am. J. Physiol. Renal Physiol. 283:F1151-9 (2002)

Ask a Question through Patient Portal

Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account

Contact Information

  • Office: 877.225.5654



  • National Jewish Health Main Campus
    1400 Jackson St.
    Denver, CO 80206

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes.

Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.


Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.